diabetes and semaglutide Maximizing Semaglutide: Understanding the Doses for & Weight Loss 🚀 Semaglutide : A Game

Reducing this risk is a key part of our commitment to driving change for this community, as we work to increase manufacturing capacity to responsibly supply this important medicine. The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established cardiovascular disease and without diabetes

Special Considerations for Different Patient Populations For Older Adults: Maintaining Independence Seniors need extra attention to muscle preservation during GLP-1 therapy

"What may be happening, and we don't know for sure, is that when you stop them, your body's left in a GLP-1 deficit which has a major impact on the satiety signal going to the brain," says Whyte

SOURCE Ouellette, Samantha, et al